Technical Analysis for MCRB - Seres Therapeutics, Inc.

Grade Last Price % Change Price Change
F 7.12 9.37% 0.61
MCRB closed up 9.37 percent on Friday, September 17, 2021, on 3.56 times normal volume.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Up
Historical MCRB trend table...

Date Alert Name Type % Chg
1,2,3 Retracement Bearish Bearish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
20 DMA Support Bullish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Volume Surge Other 0.00%
Above Upper BB Strength 0.00%
Up 3 Days in a Row Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
20 DMA Support Bullish 9.37%
Slingshot Bearish Bearish Swing Setup 12.13%
Older End-of-Day Signals for MCRB ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Up 5% 1 day ago
Rose Above Previous Day's High 1 day ago
Up 3% 1 day ago
10 DMA Support 1 day ago
Up 2% 1 day ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Seres Therapeutics, Inc. Description

Seres Therapeutics, Inc., a microbiome therapeutics platform company, focuses on the development of biological drugs designed to restore health by repairing the function of a dysbiotic microbiome. Its lead product candidate is SER-109, a bacterial spore ecology, which has completed open label Phase Ib/2 clinical study for the prevention of further recurrences of Clostridium difficile infection (CDI). The company's product candidates in pre-clinical development comprise SER-262, an Ecobiotic microbiome therapeutic designed to be used following antibiotic treatment of primary CDI to prevent the initial recurrence of CDI; SER-287 to treat inflammatory bowel disease, including ulcerative colitis; and SER-155 to treat enteric pathogens, such as antibiotic-resistant bacteria. The company was formerly known as Seres Health, Inc. and changed its name to Seres Therapeutics, Inc. in May 2015. Seres Therapeutics, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Clinical Development Autoimmune Diseases Antibiotic Inflammatory Bowel Disease Ulcer Colitis Ulcerative Colitis Diarrhea Antimicrobial Resistance Digestive Diseases Clostridioides Difficile Cdi Clostridium Difficile Clostridium Difficile Infection

Is MCRB a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 38.5
52 Week Low 5.41
Average Volume 2,338,446
200-Day Moving Average 19.09
50-Day Moving Average 9.18
20-Day Moving Average 6.34
10-Day Moving Average 6.38
Average True Range 0.58
ADX 47.65
+DI 21.76
-DI 27.41
Chandelier Exit (Long, 3 ATRs) 5.42
Chandelier Exit (Short, 3 ATRs) 7.14
Upper Bollinger Bands 7.05
Lower Bollinger Band 5.63
Percent B (%b) 1.05
BandWidth 22.46
MACD Line -0.64
MACD Signal Line -0.96
MACD Histogram 0.3155
Fundamentals Value
Market Cap 649.69 Million
Num Shares 91.2 Million
EPS -1.87
Price-to-Earnings (P/E) Ratio -3.82
Price-to-Sales 92.84
Price-to-Book 14.08
PEG Ratio -0.11
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 8.35
Resistance 3 (R3) 8.22 7.69 8.15
Resistance 2 (R2) 7.69 7.37 7.75 8.08
Resistance 1 (R1) 7.40 7.18 7.55 7.53 8.01
Pivot Point 6.87 6.87 6.94 6.93 6.87
Support 1 (S1) 6.58 6.55 6.73 6.71 6.23
Support 2 (S2) 6.05 6.36 6.11 6.16
Support 3 (S3) 5.76 6.05 6.10
Support 4 (S4) 5.89